SALIX DIN 00116238
Health Canada record
| Active ingredient(s) | FUROSEMIDE 50 MG |
|---|---|
| Dosage form | Solution |
| Route | Intravenous; Intramuscular |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Veterinary |
| ATC | |
| Original market date | 31-Dec-1986 |
| Current status date | 06-Mar-2015 |
| Source | Health Canada DPD |
Establishment licence of the holder
Intervet Canada Corp. — licence 100147, currently licensed, last inspection rating C (2023-07-17).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing FUROSEMIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00396788 | APO-FUROSEMIDE | APOTEX INC | Tablet | FUROSEMIDE 20 MG | Marketed |
| 00707570 | APO-FUROSEMIDE | APOTEX INC | Tablet | FUROSEMIDE 80 MG | Marketed |
| 00362166 | APO-FUROSEMIDE | APOTEX INC | Tablet | FUROSEMIDE 40 MG | Marketed |
| 00527033 | FUROSEMIDE INJ USP | SANDOZ CANADA INCORPORATED | Liquid | FUROSEMIDE 10 MG | Marketed |
| 02224720 | LASIX ORAL SOLUTION | SANOFI-AVENTIS CANADA INC | Solution | FUROSEMIDE 10 MG | Marketed |
| 02224755 | LASIX SPECIAL | SANOFI-AVENTIS CANADA INC | Tablet | FUROSEMIDE 500 MG | Marketed |
| 00397792 | PRO-FUROSEMIDE | PRO DOC LIMITEE | Tablet | FUROSEMIDE 40 MG | Marketed |
| 00667080 | PRO-FUROSEMIDE | PRO DOC LIMITEE | Tablet | FUROSEMIDE 80 MG | Marketed |
| 00496723 | PRO-FUROSEMIDE | PRO DOC LIMITEE | Tablet | FUROSEMIDE 20 MG | Marketed |
| 00337730 | TEVA-FUROSEMIDE | TEVA CANADA LIMITED | Tablet | FUROSEMIDE 20 MG | Marketed |
| 00765953 | TEVA-FUROSEMIDE | TEVA CANADA LIMITED | Tablet | FUROSEMIDE 80 MG | Marketed |
| 00337749 | TEVA-FUROSEMIDE | TEVA CANADA LIMITED | Tablet | FUROSEMIDE 40 MG | Marketed |
| 02364581 | AVA-FUROSEMIDE | AVANSTRA INC | Tablet | FUROSEMIDE 40 MG | Cancelled Post Market |
| 02364573 | AVA-FUROSEMIDE | AVANSTRA INC | Tablet | FUROSEMIDE 20 MG | Cancelled Post Market |
| 02247372 | BIO-FUROSEMIDE | BIOMED PHARMA | Tablet | FUROSEMIDE 40 MG | Cancelled Post Market |
| 02247371 | BIO-FUROSEMIDE | BIOMED PHARMA | Tablet | FUROSEMIDE 20 MG | Cancelled Post Market |
| 02248125 | DOM-FUROSEMIDE | BIOMED PHARMA | Tablet | FUROSEMIDE 40 MG | Cancelled Post Market |
| 02248124 | DOM-FUROSEMIDE | BIOMED PHARMA | Tablet | FUROSEMIDE 20 MG | Cancelled Post Market |
| 02351447 | FUROSEMIDE | SANIS HEALTH INC | Tablet | FUROSEMIDE 80 MG | Cancelled Post Market |
| 02351439 | FUROSEMIDE | SANIS HEALTH INC | Tablet | FUROSEMIDE 40 MG | Cancelled Post Market |
| 02351420 | FUROSEMIDE | SANIS HEALTH INC | Tablet | FUROSEMIDE 20 MG | Cancelled Post Market |
| 02232752 | FUROSEMIDE 20MG TABLETS | LABORATOIRES CONFAB INC | Tablet | FUROSEMIDE 20 MG | Cancelled Pre Market |
| 00431052 | FUROSEMIDE 40MG TAB | DUCHESNAY INC | Tablet | FUROSEMIDE 40 MG | Cancelled Post Market |
| 02232753 | FUROSEMIDE 40MG TABLETS | LABORATOIRES CONFAB INC | Tablet | FUROSEMIDE 40 MG | Cancelled Pre Market |
| 00366854 | FUROSEMIDE INJ 10MG/ML | INTERNATIONAL MEDICATION SYSTEMS LTD. | Liquid | FUROSEMIDE 10 MG | Cancelled Post Market |
| 02360365 | FUROSEMIDE INJECTION | OMEGA LABORATORIES LIMITED | Liquid | FUROSEMIDE 10 MG | Cancelled Post Market |
| 02244958 | FUROSEMIDE INJECTION SANDOZ STANDARD | SANDOZ CANADA INCORPORATED | Solution | FUROSEMIDE 50 MG | Cancelled Post Market |
| 00565040 | FUROSEMIDE INJECTION USP | HOSPIRA HEALTHCARE ULC | Solution | FUROSEMIDE 10 MG | Cancelled Post Market |
| 00401633 | FUROSEMIDE SPECIAL | SANDOZ CANADA INCORPORATED | Solution | FUROSEMIDE 250 MG | Cancelled Post Market |
| 02360446 | FUROSEMIDE SPECIAL INJECTION | OMEGA LABORATORIES LIMITED | Liquid | FUROSEMIDE 250 MG | Cancelled Post Market |
| 00353612 | FUROSIDE TAB 20MG | ICN CANADA LTD. | Tablet | FUROSEMIDE 20 MG | Cancelled Post Market |
| 00332275 | FUROSIDE TAB 40MG | ICN CANADA LTD. | Tablet | FUROSEMIDE 40 MG | Cancelled Post Market |
| 02224690 | LASIX | SANOFI-AVENTIS CANADA INC | Tablet | FUROSEMIDE 20 MG | Cancelled Post Market |
| 02224704 | LASIX | SANOFI-AVENTIS CANADA INC | Tablet | FUROSEMIDE 40 MG | Cancelled Post Market |
| 02224712 | LASIX - TAB 80MG | AVENTIS PHARMA INC | Tablet | FUROSEMIDE 80 MG | Cancelled Post Market |
| 00441198 | LASIX 2G BOL-O-TABS | INTERVET CANADA CORP | Tablet | FUROSEMIDE 2 G | Cancelled Post Market |
| 01987798 | LASIX 40MG TABLETS | HOECHST ROUSSEL CANADA INC. | Tablet | FUROSEMIDE 40 MG | Cancelled Post Market |
| 01987771 | LASIX 80MG TABLETS | HOECHST ROUSSEL CANADA INC. | Tablet | FUROSEMIDE 80 MG | Cancelled Post Market |
| 01996436 | LASIX INJECTION 10MG/ML | HOECHST ROUSSEL CANADA INC. | Liquid | FUROSEMIDE 10 MG | Cancelled Post Market |
| 02224739 | LASIX INJECTION 10MG/ML - IM IV | HOECHST MARION ROUSSEL CANADA INC. | Liquid | FUROSEMIDE 10 MG | Cancelled Post Market |
| 00432342 | LASIX ORAL SOLN 10MG/ML | HOECHST CANADA INC. | Liquid | FUROSEMIDE 10 MG | Cancelled Post Market |
| 01987585 | LASIX ORAL SOLUTION 10MG/ML | HOECHST ROUSSEL CANADA INC. | Liquid | FUROSEMIDE 10 MG | Cancelled Post Market |
| 00217743 | LASIX PARENTERAL INJ | HOECHST CANADA INC. | Liquid | FUROSEMIDE 20 MG | Cancelled Post Market |
| 01988832 | LASIX PARENTERAL INJECTION 10MG/ML | HOECHST ROUSSEL CANADA INC. | Liquid | FUROSEMIDE 10 MG | Cancelled Post Market |
| 00380024 | LASIX SPECIAL INJ 10MG/ML | HOECHST CANADA INC. | Liquid | FUROSEMIDE 10 MG | Cancelled Post Market |
| 00380016 | LASIX SPECIAL TAB 500MG | HOECHST CANADA INC. | Tablet | FUROSEMIDE 500 MG | Cancelled Post Market |
| 01987615 | LASIX SPECIAL TABLETS 500MG | HOECHST ROUSSEL CANADA INC. | Tablet | FUROSEMIDE 500 MG | Cancelled Post Market |
| 00289590 | LASIX TAB 20MG | HOECHST CANADA INC. | Tablet | FUROSEMIDE 20 MG | Cancelled Post Market |
| 01987739 | LASIX TAB 20MG | HOECHST ROUSSEL CANADA INC. | Tablet | FUROSEMIDE 20 MG | Cancelled Post Market |
| 00397687 | LASIX TAB 80MG | HOECHST CANADA INC. | Tablet | FUROSEMIDE 80 MG | Cancelled Post Market |
| 00012580 | LASIX TABS 40 MG | HOECHST CANADA INC. | Tablet | FUROSEMIDE 40 MG | Cancelled Post Market |
| 02348314 | NTP-FUROSEMIDE | TEVA CANADA LIMITED | Tablet | FUROSEMIDE 80 MG | Cancelled Pre Market |
| 02348292 | NTP-FUROSEMIDE | TEVA CANADA LIMITED | Tablet | FUROSEMIDE 20 MG | Cancelled Pre Market |
| 02348306 | NTP-FUROSEMIDE | TEVA CANADA LIMITED | Tablet | FUROSEMIDE 40 MG | Cancelled Pre Market |
| 02239226 | NU-FUROSEMIDE TABLETS | NU-PHARM INC | Tablet | FUROSEMIDE 80 MG | Cancelled (Unreturned Annual) |
| 02239225 | NU-FUROSEMIDE TABLETS | NU-PHARM INC | Tablet | FUROSEMIDE 40 MG | Cancelled Post Market |
| 02239224 | NU-FUROSEMIDE TABLETS | NU-PHARM INC | Tablet | FUROSEMIDE 20 MG | Cancelled Post Market |
| 02247494 | PMS-FUROSEMIDE | PHARMASCIENCE INC | Tablet | FUROSEMIDE 40 MG | Dormant |
| 02247493 | PMS-FUROSEMIDE | PHARMASCIENCE INC | Tablet | FUROSEMIDE 20 MG | Dormant |
| 00344079 | URITOL TAB | CARTER-HORNER CORP. | Tablet | FUROSEMIDE 40 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 20968 | 2018-06-11 | Supplement to a New Drug Submission (SNDS) | ADDITION OF A DRUG SUBSTANCE MANUFACTURER |
| 19362 | 2017-05-26 | Supplement to a New Drug Submission (SNDS) | MANUFACTURING CHANGES |
| 16655 | 2015-03-05 | Supplement to a New Drug Submission (SNDS) | CHEMISTRY AND MANUFACTURING CHANGES, LABELLING UPDATE |
| 5920 | 2004-11-26 | Supplement to a New Drug Submission (SNDS) | TO PROVIDE FOR A CHANGE IN THE NON-MEDICINAL INGREDIENTS |
| 6200 | 2001-06-29 | Supplement to a New Drug Submission (SNDS) | ALTERNATE SOURCE OF ACTIVE INGREDIENT |
| 6199 | 2001-06-29 | New Drug Submission (NDS) | |
| 6275 | 2000-09-28 | New Drug Submission (NDS) |
International API supply for FUROSEMIDE
8 valid EDQM Certificates of Suitability from 8 holders. 9 active FDA Drug Master Files.
Request a quote for SALIX